Laura C Pinheiro1, Xianming Tan2, Andrew F Olshan3, Stephanie B Wheeler4, Katherine E Reeder-Hayes5, Cleo A Samuel4, Bryce B Reeve4. 1. Department of Health Policy and Management, University of North Carolina, Chapel Hill, USA. lpinheir@live.unc.edu. 2. Department of Biostatistics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. 3. Department of Epidemiology, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. 4. Department of Health Policy and Management, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA. 5. University of North Carolina Breast Cancer, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA.
Abstract
PURPOSE: We aimed to identify subgroups of women with breast cancer who experience different health-related quality of life (HRQOL) patterns during active treatment and survivorship and determine characteristics associated with subgroup membership. METHODS: We used data from the third phase of the population-based Carolina Breast Cancer Study and included 2142 women diagnosed with breast cancer from 2008 to 2013. HRQOL was measured, on average, 5 and 25 months post diagnosis. Latent profile analysis was used to identify HRQOL latent profiles (LPs) at each time point. Latent transition analysis was used to determine probabilities of women transitioning profiles from 5 to 25 months. Multinomial logit models estimated adjusted odds ratios (aORs) and 95% confidence intervals for associations between patient characteristics and LP membership at each time point. RESULTS: We identified four HRQOL LPs at 5 and 25 months. LP1 had the poorest HRQOL and LP4 the best. Membership in the poorest profile at 5 months was associated with younger age aOR 0.95; 0.93-0.96, White race aOR 1.48; 1.25-1.65, being unmarried aOR 1.50; 1.28-1.65 and having public aOR 3.09; 1.96-4.83 or no insurance aOR 6.51; 2.12-20.10. At 25 months, Black race aOR 1.75; 1.18-1.82 was associated with the poorest profile membership. Black race and smoking were predictors of deteriorating to a worse profile from 5 to 25 months. CONCLUSIONS: Our results suggest patient-level characteristics including age at diagnosis and race may identify women at risk for experiencing poor HRQOL patterns. If women are identified and offered targeted HRQOL support, we may see improvements in long-term HRQOL and better breast cancer outcomes.
PURPOSE: We aimed to identify subgroups of women with breast cancer who experience different health-related quality of life (HRQOL) patterns during active treatment and survivorship and determine characteristics associated with subgroup membership. METHODS: We used data from the third phase of the population-based Carolina Breast Cancer Study and included 2142 women diagnosed with breast cancer from 2008 to 2013. HRQOL was measured, on average, 5 and 25 months post diagnosis. Latent profile analysis was used to identify HRQOL latent profiles (LPs) at each time point. Latent transition analysis was used to determine probabilities of women transitioning profiles from 5 to 25 months. Multinomial logit models estimated adjusted odds ratios (aORs) and 95% confidence intervals for associations between patient characteristics and LP membership at each time point. RESULTS: We identified four HRQOL LPs at 5 and 25 months. LP1 had the poorest HRQOL and LP4 the best. Membership in the poorest profile at 5 months was associated with younger age aOR 0.95; 0.93-0.96, White race aOR 1.48; 1.25-1.65, being unmarried aOR 1.50; 1.28-1.65 and having public aOR 3.09; 1.96-4.83 or no insurance aOR 6.51; 2.12-20.10. At 25 months, Black race aOR 1.75; 1.18-1.82 was associated with the poorest profile membership. Black race and smoking were predictors of deteriorating to a worse profile from 5 to 25 months. CONCLUSIONS: Our results suggest patient-level characteristics including age at diagnosis and race may identify women at risk for experiencing poor HRQOL patterns. If women are identified and offered targeted HRQOL support, we may see improvements in long-term HRQOL and better breast cancer outcomes.
Entities:
Keywords:
Breast cancer; Health-related quality of life; Latent profiles
Authors: Tyler W Buckner; Jichuan Wang; Darren A DeWalt; Shana Jacobs; Bryce B Reeve; Pamela S Hinds Journal: Pediatr Blood Cancer Date: 2014-03-15 Impact factor: 3.167
Authors: Russell E Glasgow; Robert M Kaplan; Judith K Ockene; Edwin B Fisher; Karen M Emmons Journal: Health Aff (Millwood) Date: 2012-03 Impact factor: 6.301
Authors: M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto Journal: J Clin Oncol Date: 1997-03 Impact factor: 44.544
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Jihyoung Cho; So-Youn Jung; Jung Eun Lee; Eun-Jung Shim; Nam Hyoung Kim; Zisun Kim; Guiyun Sohn; Hyun Jo Youn; Ku Sang Kim; Hanna Kim; Jong Won Lee; Min Hyuk Lee Journal: J Breast Cancer Date: 2014-09-30 Impact factor: 3.588
Authors: Alessandro A Jammal; Nara G Ogata; Fábio B Daga; Ricardo Y Abe; Vital P Costa; Felipe A Medeiros Journal: Am J Ophthalmol Date: 2018-09-17 Impact factor: 5.258
Authors: Kelly M de Ligt; Belle H de Rooij; Iris Walraven; Marianne J Heins; Janneke Verloop; Sabine Siesling; Joke C Korevaar; Lonneke V van de Poll-Franse Journal: Support Care Cancer Date: 2022-06-21 Impact factor: 3.359
Authors: Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester Journal: Curr Breast Cancer Rep Date: 2020-05-14
Authors: Jihye Park; Juan L Rodriguez; Katie M O'Brien; Hazel B Nichols; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler Journal: Cancer Date: 2020-11-25 Impact factor: 6.921
Authors: Felix J Clouth; Arturo Moncada-Torres; Gijs Geleijnse; Floortje Mols; Felice N van Erning; Ignace H J T de Hingh; Steffen C Pauws; Lonneke V van de Poll-Franse; Jeroen K Vermunt Journal: Oncologist Date: 2021-01-11